Al-Azhar University Faculty of Medicine
Cairo, Egypt
NCT Number: NCT04543422
the present randomized placebo-controlled study aimed to evaluate the effect of green tea extract administration on the clinical and neurophysiological parameters in patients with mild-to-moderate diabetic peripheral neuropathy.
Looking for future studies?
Notify Me20 year–80 year
All sexes
Interventional
Not applicable
Cairo, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Green tea extract capsules
Placebo containing inert material.
Time frame: three months
Improvement describes the difference between baseline and post-intervention outcome parameters
Looking for future studies?
Notify MeEgyptian Biomedical Research Network
Network
Green Tea Extracts for Mild-to-moderate Diabetic Peripheral Neuropathy A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07818993
Diabetic Peripheral Neuropathy
Koper, Urban Municipality of Koper, Slovenia
View Trial DetailsNCT06797869
Diabetes Mellitus, Diabetes Mellitus, Type 2
La Mesa, California, United States
View Trial DetailsNCT07616661
Diabetic Peripheral Neuropathy
Faisalābad, Punjab Province, Pakistan
View Trial DetailsNCT06074562
Diabetic Peripheral Neuropathy
Chandler, Arizona, United States
View Trial Details